| FDA | The United States Food and Drug Administration |
| GLMM | Generalized linear mixed models |
| GRADE | Grading of Recommendations, Assessment, Development, and Evaluation |
| IQR | Interquartile range |
| MMF/MPA | Mycophenolic acid |
| mTOR | Mammalian target of rapamycin |
| PRISMA | Preferred Reporting Items for Systematic Reviews and Meta-Analysis guidelines |
| PROSPERO | Prospective International Register of Systematic Reviews |
| RCT | Randomized controlled trial |
| ROBINS-I | Risk of Bias in Nonrandomized Studies of Intervention |
| SD | Standard deviation |